KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is explaining why a medication undergoes multiple
phases of testing before becoming widely available. Which
statement by the nurse best describes the primary purpose of
large Phase III clinical trials?
A. To determine whether the drug has activity in laboratory
animals
B. To evaluate safety and effectiveness in a larger patient
population before regulatory review
C. To identify the chemical structure of the drug
D. To establish manufacturing procedures for commercial
production
Correct Answer: B
Rationale:
Phase III clinical trials evaluate a medication's safety and
effectiveness in a large population of patients with the target
condition. These studies provide critical evidence for regulatory
agencies when deciding whether a drug should be approved for
clinical use. Option A describes preclinical testing. Option C
occurs during drug discovery. Option D is part of pharmaceutical
manufacturing rather than the primary objective of Phase III
trials.
,Question 2
A nurse administers a medication that binds to specific
receptors and produces the maximum possible physiologic
response. Which pharmacologic property does this best
demonstrate?
A. Potency
B. Efficacy
C. Bioavailability
D. Half-life
Correct Answer: B
Rationale:
Efficacy refers to the maximum therapeutic effect a drug can
produce regardless of dose. A drug with high efficacy can
achieve the desired clinical response when appropriate
receptors are activated. Potency (Option A) refers to the
amount of drug required to produce a given effect.
Bioavailability (Option C) is the fraction of administered drug
reaching systemic circulation. Half-life (Option D) describes the
time required for plasma drug concentration to decrease by
half.
Question 3
, A patient asks why a generic medication was substituted for a
brand-name prescription. Which response by the nurse is most
appropriate?
A. "Generic medications usually contain different active
ingredients."
B. "Generic medications are required to demonstrate
comparable bioavailability to the reference product."
C. "Generic medications are always more effective than brand-
name drugs."
D. "Generic medications do not undergo quality testing."
Correct Answer: B
Rationale:
Approved generic medications must demonstrate
bioequivalence, meaning comparable bioavailability and
expected therapeutic performance relative to the reference
product. They contain the same active ingredient, dosage form,
strength, and route of administration. Options A, C, and D are
inaccurate.
Question 4
A nurse is reviewing factors that influence oral drug absorption.
Which patient condition would most likely delay absorption of
an oral medication?
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is explaining why a medication undergoes multiple
phases of testing before becoming widely available. Which
statement by the nurse best describes the primary purpose of
large Phase III clinical trials?
A. To determine whether the drug has activity in laboratory
animals
B. To evaluate safety and effectiveness in a larger patient
population before regulatory review
C. To identify the chemical structure of the drug
D. To establish manufacturing procedures for commercial
production
Correct Answer: B
Rationale:
Phase III clinical trials evaluate a medication's safety and
effectiveness in a large population of patients with the target
condition. These studies provide critical evidence for regulatory
agencies when deciding whether a drug should be approved for
clinical use. Option A describes preclinical testing. Option C
occurs during drug discovery. Option D is part of pharmaceutical
manufacturing rather than the primary objective of Phase III
trials.
,Question 2
A nurse administers a medication that binds to specific
receptors and produces the maximum possible physiologic
response. Which pharmacologic property does this best
demonstrate?
A. Potency
B. Efficacy
C. Bioavailability
D. Half-life
Correct Answer: B
Rationale:
Efficacy refers to the maximum therapeutic effect a drug can
produce regardless of dose. A drug with high efficacy can
achieve the desired clinical response when appropriate
receptors are activated. Potency (Option A) refers to the
amount of drug required to produce a given effect.
Bioavailability (Option C) is the fraction of administered drug
reaching systemic circulation. Half-life (Option D) describes the
time required for plasma drug concentration to decrease by
half.
Question 3
, A patient asks why a generic medication was substituted for a
brand-name prescription. Which response by the nurse is most
appropriate?
A. "Generic medications usually contain different active
ingredients."
B. "Generic medications are required to demonstrate
comparable bioavailability to the reference product."
C. "Generic medications are always more effective than brand-
name drugs."
D. "Generic medications do not undergo quality testing."
Correct Answer: B
Rationale:
Approved generic medications must demonstrate
bioequivalence, meaning comparable bioavailability and
expected therapeutic performance relative to the reference
product. They contain the same active ingredient, dosage form,
strength, and route of administration. Options A, C, and D are
inaccurate.
Question 4
A nurse is reviewing factors that influence oral drug absorption.
Which patient condition would most likely delay absorption of
an oral medication?
